professorPKUCare Luzhong HospitalZibo, Shandong, China (People's Republic)
PB0242 - A phase I tiral evaluating safety and pharmacokinetics in human and an ex vivo pharmacodynamics study in hemophilia patients of KN057, the first anti–TFPI monoclonal antibody in China
Sunday, June 23, 202413:45 – 14:45 ICT
